Role of inflammatory mediators in the pathogenesis of epilepsy.
about
Long-term electrical stimulation at ear and electro-acupuncture at ST36-ST37 attenuated COX-2 in the CA1 of hippocampus in kainic acid-induced epileptic seizure rats.Molecular and clinical aspects of drug-induced gingival overgrowth.Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling.Montelukast reduces seizures in pentylenetetrazol-kindled miceAnti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideEverolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures.Anticonvulsive activity of (1S)-(-)-verbenone involving RNA expression of BDNF, COX-2, and c-fos.Antiepileptic drug therapy and recommendations for withdrawal in patients with seizures and epilepsy due to neurocysticercosis.Pediatric Autoimmune Epileptic Encephalopathies.Interleukin-21 expression in hippocampal astrocytes is enhanced following kainic acid-induced seizures.Preclinical evidence of ghrelin as a therapeutic target in epilepsy.Seizure following the Use of the COX-2 Inhibitor Etoricoxib.Deep brain stimulation of the anterior nucleus of the thalamus for drug-resistant epilepsy.Resveratrol suppressed seizures by attenuating IL-1β, IL1-Ra, IL-6, and TNF-α in the hippocampus and cortex of kindled mice.The role of inflammation in the development of epilepsy.HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
P2860
Q33674451-6442DDB0-1B54-4BC4-A5EB-0718099469FBQ34462674-2EB8D93B-4CD6-4AA2-9910-4DA38D71DAB1Q36606116-324A243E-EBAB-4FA7-A571-4F50C21BD76DQ36688813-1C2939FB-B934-4AA8-885E-C85C302438DFQ37340703-5397153B-1F1F-4BB4-A56E-15CCA63C4142Q37597272-2D58A463-DD00-4A5C-A4CD-7B4C1646BBF9Q38747432-265C1FBC-C3D0-4789-A61E-02DBD3B1FE82Q38844933-8CE5392F-1044-4734-A0F5-D7040BBBE1ACQ39068563-57F762CA-20D3-472B-88C1-DE324DB4E1FDQ39818529-9A0FED33-C99C-42CF-9A73-1E85D1BB36C0Q41709155-CB5C5D8B-F024-41F8-91C8-7F9466B51690Q42101904-2F600125-7893-4D6C-8164-6DA790C8B64EQ47558327-AE38A08F-0782-4DE9-A68C-F99D4F908CBCQ48214403-6B309044-DEF1-44ED-A06B-5D84EE1674CAQ55265934-8B89EB36-AD19-43DF-9C29-42D18CD255D9Q57113385-8433DC24-57EB-4C99-B0C0-3C04C072D898
P2860
Role of inflammatory mediators in the pathogenesis of epilepsy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Role of inflammatory mediators in the pathogenesis of epilepsy.
@ast
Role of inflammatory mediators in the pathogenesis of epilepsy.
@en
Role of inflammatory mediators in the pathogenesis of epilepsy.
@nl
type
label
Role of inflammatory mediators in the pathogenesis of epilepsy.
@ast
Role of inflammatory mediators in the pathogenesis of epilepsy.
@en
Role of inflammatory mediators in the pathogenesis of epilepsy.
@nl
prefLabel
Role of inflammatory mediators in the pathogenesis of epilepsy.
@ast
Role of inflammatory mediators in the pathogenesis of epilepsy.
@en
Role of inflammatory mediators in the pathogenesis of epilepsy.
@nl
P2860
P356
P1476
Role of inflammatory mediators in the pathogenesis of epilepsy
@en
P2093
Hiroko Sugiura
Kanato Yamagata
P2860
P304
P356
10.1155/2014/901902
P5008
P577
2014-08-13T00:00:00Z